1. Monitoring pharmacodynamic response to hypoxia-modifying therapy using non-invasive positron emission tomography and magnetic resonance imaging. (July 2016) Authors: Tessyman, V.; Duncan, F.; Finegan, K.; Little, R.; Cheung, S.; Watson, Y.; Babur, M.; Asselin, M.C.; O'Connor, J.; Williams, K. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0632: Oxygen enhanced-MRI is feasible, repeatable and detects radiotherapy-induced NSCLC hypoxia changes. (April 2018) Authors: Salem, A.; Little, R.A.; Featherstone, A.K.; Cheung, S.; Watson, Y.; Matthews, J.; Asselin, M.C.; Jackson, A.; Parker, G.J.M.; Faivre-Finn, C.; O'Connor, J.P.B. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S336 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗